Stay updated on CBDV vs. Placebo in Children With ASD Clinical Trial
Sign up to get notified when there's something new on the CBDV vs. Placebo in Children With ASD Clinical Trial page.

Latest updates to the CBDV vs. Placebo in Children With ASD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedMajor change: update to v3.2.0 and a prominent notice about government funding impact and operating status; removal of v3.1.0. If users rely on current operating status and versioning, this is significant.SummaryDifference3%

- Check28 days agoChange DetectedUpdate to version v3.1.0 with new contact info; older version v3.0.2 and prior topic outlines removed.SummaryDifference0.3%

- Check43 days agoChange DetectedExpanded and updated outcome measures for the ASD study, replacing Vineland-3 with VABS-3 and PedsQL with the family impact module, and adding ABC-I, RBS-R, MERS-R, and ABC-SW with Week 12 change reporting.SummaryDifference39%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has updated its facility name and location details, while also adding new publications related to drug safety and counterfeit drugs. Notably, the previous location information has been removed.SummaryDifference7%

- Check71 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to CBDV vs. Placebo in Children With ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CBDV vs. Placebo in Children With ASD Clinical Trial page.